Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review

By Costello Michael F.   Shrestha Bhushan   Eden John   Johnson Neil P.   Sjoblom Peter  

Human Reproduction, Vol. 22, Iss. 5, 2007-05 ,pp. : 1200-1209

Oxford University Press

Access to resources Recommend Favorite

Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?

By Celik Cem   Abali Remzi   Tasdemir Nicel   Guzel Savas   Yuksel Aytac   Aksu Erson   Yılmaz Murat  

Gynecological Endocrinology, Vol. 28, Iss. 8, 2012-08 ,pp. : 615-618

Informa Healthcare

Access to resources Recommend Favorite

Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis

By Barry J.A.   Kuczmierczyk A.R.   Hardiman P.J.  

Human Reproduction, Vol. 26, Iss. 9, 2011-09 ,pp. : 2442-2451

Oxford University Press

Access to resources Recommend Favorite

The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome

By Minozzi Massimo   Costantino Demetrio   Guaraldi Claudia   Unfer Vittorio  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 920-924

Informa Healthcare

Access to resources Recommend Favorite

A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome

By Costello Michael F.   Chapman Michael   Conway Una  

Human Reproduction, Vol. 21, Iss. 10, 2006-10 ,pp. : 2728-2728

Oxford University Press

Access to resources Recommend Favorite